 |  Updated:Â
Shares in London-listed drugmakers GSK and Astrazeneca tumbled on Monday morning after President Donald Trump said the US’ new pharma policy would make drug…
GSK and Astrazeneca shares slump as Trump vows drug price cut
Share this article
More News
Bithumb moves to reappoint CEO amid AML probe pressure
March 23, 2026
Pi Network (PI) Surpassed by This Viral Crypto
March 23, 2026
Investing Strategies for Energy Stocks During Iran Conflict
March 23, 2026
BTC, ETH, and XRP Drop As US-Iran War Enters Fourth Week
March 23, 2026